Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK
A rising number of non-tuberculous mycobacterial (NTM) isolates are being identified in UK clinical practice. There are many uncertainties around the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD), including its epidemiology, diagnosis, treatment and prevention. Regional vari...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-12-01
|
| Series: | BMJ Open Respiratory Research |
| Online Access: | https://bmjopenrespres.bmj.com/content/7/1/e000591.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850206232656216064 |
|---|---|
| author | Marc Lipman Tom Fardon Roald van der Laan Joanne Cleverley Besma Musaddaq Daniel Peckham Paul Whitaker Jacqui White |
| author_facet | Marc Lipman Tom Fardon Roald van der Laan Joanne Cleverley Besma Musaddaq Daniel Peckham Paul Whitaker Jacqui White |
| author_sort | Marc Lipman |
| collection | DOAJ |
| description | A rising number of non-tuberculous mycobacterial (NTM) isolates are being identified in UK clinical practice. There are many uncertainties around the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD), including its epidemiology, diagnosis, treatment and prevention. Regional variations in how patients with NTM-PD are managed reflects the lack of standardised pathways in the UK. Service optimisation and multidisciplinary working can improve the quality of care for patients with NTM-PD, including (1) better identification of patients at risk of NTM-PD and modification of risk factors where applicable; (2) standardisation of reference laboratory testing to offer clinicians access to accurate and prompt information on NTM species and drug sensitivities; (3) development of recognised specialist NTM nursing care; (4) standardisation of NTM-PD imaging strategies for monitoring of treatment and disease progression; (5) establishment of a hub-and-spoke model of care, including clear referral and management pathways, dedicated NTM-PD multidisciplinary teams, and long-term patient follow-up; (6) formation of clinical networks to link experts who manage diseases associated with NTM; (7) enabling patients to access relevant support groups that can provide information and support for their condition; and (8) development of NTM research groups to allow patient participation in clinical trials and to facilitate professional education. |
| format | Article |
| id | doaj-art-b2f39751e66f4dfda7e718ebddfe9536 |
| institution | OA Journals |
| issn | 2052-4439 |
| language | English |
| publishDate | 2020-12-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open Respiratory Research |
| spelling | doaj-art-b2f39751e66f4dfda7e718ebddfe95362025-08-20T02:10:53ZengBMJ Publishing GroupBMJ Open Respiratory Research2052-44392020-12-017110.1136/bmjresp-2020-000591Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UKMarc Lipman0Tom Fardon1Roald van der Laan2Joanne Cleverley3Besma Musaddaq4Daniel Peckham5Paul Whitaker6Jacqui White7Royal Free London Hospital NHS Foundation Trust, London, UK6 Respiratory Medicine, University of Dundee, Dundee, UKInsmed Netherlands BV, Utrecht, The NetherlandsDepartment of Radiology, Royal Free Hospital, London, UKDepartment of Radiology, Royal Free Hospital, London, UKLeeds Institute of Medical Research, University of Leeds, Leeds, UKLeeds Centre for Cystic Fibrosis, St Jamess University Hospital, Leeds, UKDepartment of Palliative Care, Barwon Health, Geelong, Victoria, AustraliaA rising number of non-tuberculous mycobacterial (NTM) isolates are being identified in UK clinical practice. There are many uncertainties around the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD), including its epidemiology, diagnosis, treatment and prevention. Regional variations in how patients with NTM-PD are managed reflects the lack of standardised pathways in the UK. Service optimisation and multidisciplinary working can improve the quality of care for patients with NTM-PD, including (1) better identification of patients at risk of NTM-PD and modification of risk factors where applicable; (2) standardisation of reference laboratory testing to offer clinicians access to accurate and prompt information on NTM species and drug sensitivities; (3) development of recognised specialist NTM nursing care; (4) standardisation of NTM-PD imaging strategies for monitoring of treatment and disease progression; (5) establishment of a hub-and-spoke model of care, including clear referral and management pathways, dedicated NTM-PD multidisciplinary teams, and long-term patient follow-up; (6) formation of clinical networks to link experts who manage diseases associated with NTM; (7) enabling patients to access relevant support groups that can provide information and support for their condition; and (8) development of NTM research groups to allow patient participation in clinical trials and to facilitate professional education.https://bmjopenrespres.bmj.com/content/7/1/e000591.full |
| spellingShingle | Marc Lipman Tom Fardon Roald van der Laan Joanne Cleverley Besma Musaddaq Daniel Peckham Paul Whitaker Jacqui White Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK BMJ Open Respiratory Research |
| title | Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK |
| title_full | Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK |
| title_fullStr | Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK |
| title_full_unstemmed | Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK |
| title_short | Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK |
| title_sort | current and future management of non tuberculous mycobacterial pulmonary disease ntm pd in the uk |
| url | https://bmjopenrespres.bmj.com/content/7/1/e000591.full |
| work_keys_str_mv | AT marclipman currentandfuturemanagementofnontuberculousmycobacterialpulmonarydiseasentmpdintheuk AT tomfardon currentandfuturemanagementofnontuberculousmycobacterialpulmonarydiseasentmpdintheuk AT roaldvanderlaan currentandfuturemanagementofnontuberculousmycobacterialpulmonarydiseasentmpdintheuk AT joannecleverley currentandfuturemanagementofnontuberculousmycobacterialpulmonarydiseasentmpdintheuk AT besmamusaddaq currentandfuturemanagementofnontuberculousmycobacterialpulmonarydiseasentmpdintheuk AT danielpeckham currentandfuturemanagementofnontuberculousmycobacterialpulmonarydiseasentmpdintheuk AT paulwhitaker currentandfuturemanagementofnontuberculousmycobacterialpulmonarydiseasentmpdintheuk AT jacquiwhite currentandfuturemanagementofnontuberculousmycobacterialpulmonarydiseasentmpdintheuk |